Vonoprazan (Voquezna) was noninferior to lansoprazole (Prevacid) for healing patients with erosive esophagitis, and was superior for maintaining healing, a randomized trial showed. In a modified ...

The US Food and Drug Administration (FDA) has approved vonoprazan 10 mg and 20 mg tablets (Voquezna, Phathom Pharmaceuticals) for the healing and maintenance of healing of all grades of erosive ...

Gastroesophageal reflux disease (GERD) is one of the most common disorders of the gastrointestinal tract, with a pooled prevalence of 21% in the U.S., accounting for more than 4.6 million ambulatory ...

Credit: Phathom Pharmaceuticals. Voquezna, a potassium-competitive acid blocker, is supplied as 10mg and 20mg tablets. Voquezna ® (vonoprazan) is now available for the treatment of erosive esophagitis ...

BUFFALO GROVE, Ill.--(BUSINESS WIRE)-- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for ...

The oral potassium-competitive acid blocker (PCAB) vonoprazan was noninferior and superior to the proton pump inhibitor (PPI) lansoprazole for erosive esophagitis, according to results of the phase 3 ...

Los Angeles, CA – New clinical data demonstrated, for the first time in a prospective study, a direct relationship between controlling gastric (or stomach) acid and healing erosive esophagitis caused ...

throat The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis. The New ...

DEAR DR. ROACH: I am 63 years old, and four weeks ago, I was diagnosed by my gastroenterologist with erosive esophagitis after an endoscopy. I was placed initially on Protonix, but I didn’t improve ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Phathom Pharmaceuticals’ Voquezna tablets 10 mg and 20 mg to treat erosive esophagitis, or ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 63 years old, and four weeks ago, I was diagnosed by my ...